Упрощенная HTML-версия
146. Kaminski N.V. Suppression of humoral and cell-mediated immune responses by
carbon tetrachlonde / N.V. Kaminski, S.D. Jordan, H.P. Hotsapple // AppI. Toxicol. — 1999. —
Vol. 12,№ 1.—P. 117—128.
147. Katsumata T.T. Alterations in calcium content and Ca2-ATP-ase activity in the liver
of rats orally administered carbon tetrachloride / T.T. Katsumata, Murata, M. Yamagushi // Mol.
Cell. Biochem. — 1998. — Vol. 185, № 1—2. — P. 253—259.
148. Laslen T.I. Effect of cyclophosphamide administration on the activity and relative
content of hepatic P4502D1 in rat / T.I. Laslen, F. Alvarez, R.L. Nation // Xenobiotica. — 1995. —
Vol. 25, № 10.—P. 1031—1039.
149. Lee J. Ethanol co-exposure increases lethality of allyl alcohol in male Sprague-
Dawley rats / J. Lee, M. Chung// J. Toxicol. Environ. Health. — 1999. — Vol. 56, № 2. — P. 12
1—130.
150. Lee J. Drug-induced hepatotoxicity // Aliment. Pharmacol. Ther. — 1993. — Vol. 7,
№ 5. — P. 477—485.
151. Lekim D. On the pharmacokinetics of orally applied essential phospholipide (EPL) //
Phosphatidyicholine. Biochemical and clinical aspects of essential phospholipids. — Berlin;
Heidelberg; New York, 1986. —P.48—56.
152. Ma B. Acute toxicity of adjuyant doxorubicin and cyclophosphamide for early
breastcancer — a retrospective review of Chinese patients and comparison with anhistoric Western
series / B. Ma, W. Yeo, P.Hui. // Radiother. Oncol. —2002. — Vol. 62, № 2.—P. 185—189.
153. Mehendate H. Novel mechanisms in chemically induced hepatotoxicity / H.
Mehendate R. Roth, A. Gandotfi // FASEB J. — 1994. — Vol. 8, №15. — P. 1285—1295.
154. Millat B. Acute pancreatitis: ethiology, diagnosis, prognosis // Rev. Pract. — 1999.—
Vol. 49, №3.—P. 311—319.
155. Morazzoni P. Comparative bioavailability of silipide a new fiavanolignan complex in
rats / P. Morazzoni, M. J. Magistretti, C. Giachetti, G. Zanolo // Eur. 3. Drag. Metab. Pharmacorinet.
— 1992. — Vol. 17, № 1. — P. 39—44.
156. Morazzoni P. Comparative pharmacokinetics of silipide and silymarin in rat /
P.Morazzoni, A. Montatbetti, Matandrino, G. Spfferi // Eur. J. Drag. Metab. Pharmacokinet. —
1993.— Vol. 18, №3.—P. 289—297.
157. Niederau C. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment
of chronic hepatitis D and C: multi-center, randomized, double-blind, placebo-controlled trial / C.
Niederau, G. Strohmeyer, T. Heinges // HepatoGastroenterology. — 1998. — Vol. 45. — P. 797—
804.
158. Poli G. Liver damage due to free radicals // Br. Med. Bul. — 1993. — Vol. 49№ 3.
— P. 604—620.
159. Pumford N. Covalent binding of xenobiotics to specific proteins in the liver / N.
Pumford N. Halmes, J. Hinson // Drug Metab. Rev. — 1997. — Vol. 29, № 1—2. — P. 39—57.
160. Schandalik R. Pharmacokinetics of silybin in bile following administration of silipide
and silimarinn in cholecystectomy patients / R. Schandalik, G. Gatti, E. Perucca // Arzneimitt. —
Forsch. — 1992.— Bd. 42,№ 3.—S. 964—968.
161. Seya K. Changes in the ability of ATP synthesis in the mitochondrial membrane in
the rat liver injured by carbon tetrachloride / K. Seya, N. Ohk.ohchi, S. Mon // J. Exp. Med. —
1996. — Vol. 178, № 4. — P. 425—430.
162. Singh I. Protection of CCI4-induced liver damage in rats by some calcium channel
blockers / I. Singh, A. Kaur, S. Mathur //Indian J. Physiol. Pharmacol. — 1995. — Vol. 39, № 3.—
P. 275—278.